跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,461 条关于
“Pharma Mar, S.A.”
全部
21,461
临床试验
11,348
药物
3,637
机构
1,773
资讯
4,703
3天前
MHRA Approves Lurbinectedin Plus Atezolizumab as First-Line Maintenance in Extensive-Stage SCLC
去年
Pharma Mar SA Achieves Recruitment Milestone in Phase III Cancer Trial
去年
Oncodesign Precision Medicine Presents Positive Phase 1 Data for RIPK2 Inhibitor OPM-101 in Healthy Volunteers
去年
Marea's MAR-001 Shows Promising Lipid-Lowering Results in Phase 2a Cardiovascular Study
去年
Lymphodepletion Enhances MAR-T Cell Therapy Efficacy in Lymphoma Patients, Marker Therapeutics Reports
3个月前
Zealand Pharma Reports Share Buy-Back Progress and PDMR Transactions Amid Metabolic Health Pipeline Push
2年前
Jacobio Pharma Receives IND Approval for P53 Y220C Activator JAB-30355 in the US
2年前
Innate Pharma's IPH4502, a Nectin-4-Targeting ADC, Receives FDA IND Clearance for Phase 1 Solid Tumor Trial
11个月前
Marker Therapeutics Initiates First Off-the-Shelf T Cell Therapy Trial with Promising Early Safety Data
8个月前
Multi-Antigen T Cell Therapy Shows 84.6% Disease Control Rate in Pancreatic Cancer Phase 1/2 Trial
第 1 页,共 471 页
上一页
下一页